Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

Healthcare Biotechnology
StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

Recent & Breaking News (TSX:SZLS)

GeneNews Announces Q4 and Year End 2017 Financial Results & Provides Progress Update

Canada NewsWire April 3, 2018

GeneNews to Report Fourth Quarter and Full Year 2017 Financial Results on April 3, 2018 - Conference Call to Follow

Canada NewsWire April 2, 2018

CPP Investment Board grows presence in Hong Kong

Stockhouse Editorial December 8, 2017

GeneNews Announces Q3-2017 Financial Results & Provides Progress Update

Canada NewsWire November 15, 2017

GeneNews to Report Third Quarter 2017 Financial Results on November 15, 2017 - Conference Call to Follow

Canada NewsWire November 13, 2017

GeneNews Closes The $10 Million Milost Financing

Canada NewsWire November 9, 2017

Genmab and Seattle Genetics to Initiate New Study of Novel Antibody-Drug Conjugate Tisotumab Vedotin in Cervical Cancer

GlobeNewswire October 10, 2017

Genmab and Seattle Genetics to Co-develop Tisotumab Vedotin for Solid Tumors

GlobeNewswire August 29, 2017

IIROC Trade Resumption - GeneNews Limited

Newsfile June 29, 2017

IIROC Trade Halt - GeneNews Limited

Newsfile June 29, 2017

GeneNews Announces Q1-2017 Financial Results & Provides Progress Update

Canada NewsWire May 11, 2017

GeneNews Announces Fourth Quarter and Full Year 2016 Financial Results

Canada NewsWire April 3, 2017

GeneNews Launches Blood-Based, Biomarker Test for Breast Cancer Risk Assessment

Canada NewsWire March 29, 2017

GeneNews Retains Marcum, LLP as New Corporate Auditor

Canada NewsWire March 17, 2017

GeneNews Announces Contract with Large Multi-Specialty Physician Group For Use of Early Cancer Diagnostic Tests

Canada NewsWire March 16, 2017

GeneNews Announces Settlement Agreement with HDL Liquidating Trust

Canada NewsWire March 9, 2017

GeneNews Announces Change in Auditor

Canada NewsWire March 7, 2017

GeneNews Announces Closing of Private Placement of Convertible Debentures

Canada NewsWire December 29, 2016

IIROC Trade Resumption - GeneNews Limited

Newsfile December 5, 2016

IIROC Trade Resumption - GEN

Canada NewsWire December 5, 2016